Oncosimis
(ONCOSIMIS BIOTECH PRIVATE LIMITED)
Founded in 2016
About Oncosimis
Oncosimis Biotech is a startup that specializes in the development and production of affordable biosimilar drugs. Their focus is on improving healthcare by offering safe and effective biosimilar mAbs and recombinant proteins. They employ cutting-edge biomedical applications to address medical conditions with unmet needs, benefiting both acute and chronic disease patients.
Incubators & Accelerators of Oncosimis
Public Links of Oncosimis
Frequently Asked Questions (FAQ)
When was Oncosimis founded?
Oncosimis was founded in the year 2016.
What is the legal name of Oncosimis?
The legal name of Oncosimis is Oncosimis Biotech Private Limited.
Who are the founders of Oncosimis?
Oncosimis is founded by Lokireddy Chandra Mohan Reddy and Sudarsanareddy Lokireddy.
Which Incubators & Accelerators supported Oncosimis?
What are the focus areas of Oncosimis?
Who are Oncosimis's competitors?
Possible competitors of Oncosimis may include Aiyon Products Private Limited, Affigenix, Ameliorate Biotech and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
